Raptor Pharmaceutical Corp. Company Profile (NASDAQ:RPTP)

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RPTP
  • CUSIP: 75382F10
Key Metrics:
  • Previous Close: $7.67
  • 50 Day Moving Average: $6.45
  • 200 Day Moving Average: $5.25
  • 52-Week Range: $2.94 - $13.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -20.73
  • P/E Growth: 0.00
  • Market Cap: $654.30M
  • Outstanding Shares: 85,306,000
  • Beta: 1.31
Additional Links:
Companies Related to Raptor Pharmaceutical Corp.:

Analyst Ratings

Consensus Ratings for Raptor Pharmaceutical Corp. (NASDAQ:RPTP) (?)
Ratings Breakdown: 5 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $7.83 (2.13% upside)

Analysts' Ratings History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Show:
DateFirmActionRatingPrice TargetDetails
8/23/2016FBR & CoReiterated RatingHold$10.00View Rating Details
8/19/2016Cowen and CompanyReiterated RatingBuy$8.00View Rating Details
8/8/2016Citigroup Inc.DowngradeBuy -> Neutral$6.00 -> $8.00View Rating Details
5/6/2016WedbushReiterated RatingNeutral$4.00View Rating Details
4/12/2016Leerink SwannReiterated RatingOutperform$11.00View Rating Details
4/11/2016Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details
3/20/2016JMP SecuritiesDowngradeHoldView Rating Details
8/22/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.18)($0.16)$28.52 million$32.05 millionViewListenView Earnings Details
5/5/2016Q116($0.17)($0.17)$27.17 million$27.47 millionViewN/AView Earnings Details
2/25/2016Q415($0.19)($0.17)$26.08 million$24.67 millionViewListenView Earnings Details
11/5/2015Q315($0.18)($0.18)$24.25 million$25.80 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.12)$21.40 million$23.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.25)($0.24)$19.10 million$20.50 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.25)$20.12 million$17.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.18)($0.04)$18.90 million$23.80 millionViewN/AView Earnings Details
8/7/2014Q214($0.19)($0.15)$14.58 million$16.31 millionViewN/AView Earnings Details
5/8/2014Q413($0.17)($0.20)$11.81 million$12.10 millionViewN/AView Earnings Details
3/13/2014Q313($0.18)($0.19)$10.20 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.30)($0.30)ViewN/AView Earnings Details
3/14/2013Q1 2013($0.27)($0.37)ViewN/AView Earnings Details
1/9/2013Q1 2013($0.23)($0.26)$0.25 millionViewN/AView Earnings Details
11/14/2012Q412($0.20)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Current Year EPS Consensus Estimate: $-0.91 EPS
Next Year EPS Consensus Estimate: $-0.37 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.17)($0.15)($0.16)
Q2 20163($0.15)($0.14)($0.15)
Q3 20163($0.21)($0.15)($0.17)
Q4 20164($0.21)($0.14)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2015Suzanne Louise BruhnDirectorSell18,258$12.47$227,677.26View SEC Filing  
9/2/2015Raymond AndersonDirectorSell4,916$12.51$61,499.16View SEC Filing  
8/31/2015Raymond AndersonDirectorSell8,084$12.52$101,211.68View SEC Filing  
7/1/2015Llew KeltnerDirectorSell50,000$16.05$802,500.00View SEC Filing  
6/18/2015Thomas E DaleyInsiderSell35,000$15.00$525,000.00View SEC Filing  
6/10/2015Suzanne Louise BruhnDirectorSell30,000$13.45$403,500.00View SEC Filing  
5/4/2015Richard L FranklinDirectorSell10,000$9.61$96,100.00View SEC Filing  
4/2/2015Richard L FranklinDirectorSell10,000$10.37$103,700.00View SEC Filing  
3/23/2015Christopher M StarrDirectorSell20,033$11.62$232,783.46View SEC Filing  
3/2/2015Richard L FranklinDirectorSell10,000$9.18$91,800.00View SEC Filing  
2/24/2015Christopher M StarrDirectorSell30,000$9.52$285,600.00View SEC Filing  
2/2/2015Richard L FranklinDirectorSell7,109$9.20$65,402.80View SEC Filing  
1/22/2015Christopher M StarrDirectorSell30,000$9.45$283,500.00View SEC Filing  
1/15/2015Christopher M StarrDirectorSell30,000$9.73$291,900.00View SEC Filing  
1/12/2015Raymond AndersonDirectorSell10,000$10.58$105,800.00View SEC Filing  
12/22/2014Christopher M StarrCEOSell30,000$9.00$270,000.00View SEC Filing  
12/15/2014Christopher M StarrCEOSell30,000$8.15$244,500.00View SEC Filing  
11/24/2014Christopher M StarrCEOSell30,000$9.97$299,100.00View SEC Filing  
10/22/2014Christopher M StarrCEOSell30,000$10.25$307,500.00View SEC Filing  
9/23/2014Christopher M StarrCEOSell30,000$10.21$306,300.00View SEC Filing  
9/16/2014Christopher M StarrCEOSell32,896$10.60$348,697.60View SEC Filing  
9/10/2014Raymond AndersonDirectorSell10,000$10.81$108,100.00View SEC Filing  
8/25/2014Erich SagerDirectorSell10,000$11.01$110,100.00View SEC Filing  
7/7/2014Llew KeltnerDirectorSell10,000$11.21$112,100.00View SEC Filing  
5/13/2014Georgia ErbezCFOBuy16,100$7.90$127,190.00View SEC Filing  
4/7/2014Vijay SamantDirectorSell5,000$8.59$42,950.00View SEC Filing  
3/17/2014Christopher StarrCEOSell19,316$10.79$208,419.64View SEC Filing  
1/13/2014Timothy WalbertDirectorSell5,520$15.06$83,131.20View SEC Filing  
1/9/2014Thomas DaleyInsiderSell15,000$14.17$212,550.00View SEC Filing  
1/7/2014Llew KeltnerDirectorSell10,000$13.25$132,500.00View SEC Filing  
1/2/2014Richard FranklinDirectorSell10,715$13.12$140,580.80View SEC Filing  
12/9/2013Vijay SamantDirectorSell5,000$13.86$69,300.00View SEC Filing  
11/13/2013Timothy WalbertDirectorSell5,521$12.44$68,681.24View SEC Filing  
11/4/2013Richard FranklinDirectorSell10,715$14.88$159,439.20View SEC Filing  
10/15/2013Christopher M StarrCEOSell25,000$13.77$344,250.00View SEC Filing  
10/14/2013Suzanne Louise BruhnDirectorSell2,760$13.58$37,480.80View SEC Filing  
10/7/2013Vijay SamantDirectorSell5,000$14.76$73,800.00View SEC Filing  
9/16/2013Christopher StarrCEOSell25,000$14.21$355,250.00View SEC Filing  
9/16/2013Erich SagerDirectorSell17,000$14.21$241,570.00View SEC Filing  
9/13/2013Suzanne Louise BruhnDirectorSell2,760$14.07$38,833.20View SEC Filing  
9/9/2013Richard L FranklinDirectorSell10,715$14.24$152,581.60View SEC Filing  
9/9/2013Thomas E DaleyInsiderSell25,000$14.28$357,000.00View SEC Filing  
8/30/2013Georgia ErbezCFOSell7,400$13.42$99,308.00View SEC Filing  
12/28/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
11/26/2012Erich SagerDirectorSell11,279$5.00$56,395.00View SEC Filing  
9/12/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
DateHeadline
finance.yahoo.com logoRaptor Pharmaceutical to Present Data on QUINSAIR™ and Other Inhaled Antibiotics at the ERS International Congress (NASDAQ:RPTP)
finance.yahoo.com - August 24 at 10:15 AM
thecountrycaller.com logoWill Shire PLC (ADR) (SHPG) Move with Raptor Pharmaceutical Corp. (RPTP)? - TCC (NASDAQ:RPTP)
www.thecountrycaller.com - August 23 at 11:43 AM
insidermonkey.com logoWhat Will Retrophin Inc (RTRX) Get For Its Money On A Raptor Pharmaceutical Corp. (RPTP) Deal? (NASDAQ:RPTP)
www.insidermonkey.com - August 22 at 7:07 PM
investornewswire.com logoWill Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Hit $11 Price Target? - Investor Newswire (NASDAQ:RPTP)
www.investornewswire.com - August 19 at 7:03 PM
benzinga.com logoRaptor Pharmaceuticals: Another Case Of Mistaken Identity - Benzinga (NASDAQ:RPTP)
www.benzinga.com - August 19 at 7:03 PM
feeds.benzinga.com logoRaptor Pharmaceuticals: Another Case Of Mistaken Identity (NASDAQ:RPTP)
feeds.benzinga.com - August 19 at 3:45 PM
News IconHealthcare Gainers Attain Market Attention- Raptor Pharmaceuticals (NASDAQ:RPTP), Nymox Pharmaceutical ... - Seneca Globe (NASDAQ:RPTP)
www.senecaglobe.com - August 18 at 7:28 PM
News IconRaptor Pharmaceuticals Corp.'s (RPTP): Remarkable Stock of Recent Trading - Hot Stocks Point (NASDAQ:RPTP)
www.hotstockspoint.com - August 18 at 7:28 PM
nasdaq.com logoRaptor Pharmaceuticals (RPTP) in Focus: Stock Up 5.7% - Nasdaq (NASDAQ:RPTP)
www.nasdaq.com - August 18 at 7:28 PM
finance.yahoo.com logoRaptor Pharmaceutical Voted A “Best Places to Work” Company in the North San Francisco Bay Area (NASDAQ:RPTP)
finance.yahoo.com - August 18 at 7:28 PM
publicnow.com logoRaptor Pharmaceutical Voted A "Best Places to Work" Company in the North San Francisco Bay Area (NASDAQ:RPTP)
www.publicnow.com - August 18 at 7:28 PM
fool.com logoWhy Raptor Pharmaceutical Corp. Is Clawing Higher Today (NASDAQ:RPTP)
www.fool.com - August 18 at 1:13 PM
feeds.benzinga.com logo20 Stocks Moving In Thursday's Pre-Market Session (NASDAQ:RPTP)
feeds.benzinga.com - August 18 at 10:40 AM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP): That's How Timing The Breakout Is Significant For Quick Money - Market News Call (NASDAQ:RPTP)
www.marketnewscall.com - August 18 at 10:12 AM
bloomberg.com logoRaptor Soars After Retrophin Is Said to Consider Bid (NASDAQ:RPTP)
www.bloomberg.com - August 18 at 10:12 AM
finance.yahoo.com logoRaptor Pharmaceuticals (RPTP) in Focus: Stock Up 5.7% (NASDAQ:RPTP)
finance.yahoo.com - August 18 at 10:12 AM
seekingalpha.com logoRaptor Pharmaceuticals in play; shares up 16% premarket (NASDAQ:RPTP)
seekingalpha.com - August 18 at 9:15 AM
feeds.reuters.com logoBRIEF-Retrophin considering acquisition of Raptor Pharmaceutical- Bloomberg (NASDAQ:RPTP)
feeds.reuters.com - August 17 at 9:55 PM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP): That’s How Timing The Breakout Is Significant For Quick Money (NASDAQ:RPTP)
www.marketnewscall.com - August 17 at 7:33 PM
News IconBiotech Stocks Technical Report -- Incyte, BioDelivery Sciences Intl., Synthetic Biologics, and Raptor Pharma (NASDAQ:RPTP)
www.kait8.com - August 16 at 10:31 AM
4-traders.com logoRaptor Pharmaceutical : Biotech Stocks Technical Report -- Incyte, BioDelivery Sciences Intl., Synthetic Biologics, and Raptor Pharma (NASDAQ:RPTP)
www.4-traders.com - August 16 at 10:31 AM
finance.yahoo.com logoRAPTOR PHARMACEUTICAL CORP Financials (NASDAQ:RPTP)
finance.yahoo.com - August 12 at 7:19 PM
capitalcube.com logoETF’s with exposure to Raptor Pharmaceutical Corp. : August 11, 2016 (NASDAQ:RPTP)
www.capitalcube.com - August 11 at 7:43 PM
capitalcube.com logoRaptor Pharmaceutical Corp. :RPTP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:RPTP)
www.capitalcube.com - August 10 at 7:42 PM
benzinga.com logoCitigroup Downgrades Raptor Pharma; Concerned With Declining Investor Sentiment Around Revenue (NASDAQ:RPTP)
www.benzinga.com - August 9 at 10:27 AM
News IconIntraday Active Biotech Stocks News: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP), Galena Biopharma, Inc ... - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - August 8 at 11:58 AM
equities.com logoRaptor Pharmaceutical Corp. (RPTP) Jumps 5.67% on August 05 - Equities.com (NASDAQ:RPTP)
www.equities.com - August 6 at 7:13 PM
equities.com logoRaptor Pharmaceutical Corp. (RPTP) is Trading Higher on Unusual Volume for August 04 - Equities.com (NASDAQ:RPTP)
www.equities.com - August 6 at 9:54 AM
equities.com logoRaptor Pharmaceutical Corp. (RPTP) Jumps 5.67% on August 04 - Equities.com (NASDAQ:RPTP)
www.equities.com - August 5 at 7:25 PM
News IconA higher gross profit margin, and a sensible acquisition, have Cott investors looking up (NASDAQ:RPTP)
www.ad-hoc-news.de - August 5 at 10:11 AM
seekingalpha.com logoRaptor Pharmaceutical's (RPTP) CEO Julie Anne Smith on Q2 2016 Results - Earnings Call Transcript (NASDAQ:RPTP)
seekingalpha.com - August 5 at 10:11 AM
sg.finance.yahoo.com logoRaptor Pharmaceutical reports 2Q loss (NASDAQ:RPTP)
sg.finance.yahoo.com - August 5 at 10:11 AM
finance.yahoo.com logoEdited Transcript of RPTP earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:RPTP)
finance.yahoo.com - August 5 at 10:11 AM
News IconRaptor sales up, lead 37% increase in revenues (NASDAQ:RPTP)
www.northbaybusinessjournal.com - August 4 at 7:40 PM
rttnews.com logoEARNINGS SUMMARY: Details of Raptor Pharmaceuticals Corp. Q2 Earnings Report (NASDAQ:RPTP)
www.rttnews.com - August 4 at 7:40 PM
biz.yahoo.com logoRaptor Pharmaceutical Corp Earnings Call scheduled for 4:30 pm ET today (NASDAQ:RPTP)
biz.yahoo.com - August 4 at 7:40 PM
seekingalpha.com logoRaptor Pharmaceutical beats by $0.05, beats on revenue (NASDAQ:RPTP)
seekingalpha.com - August 4 at 4:54 PM
biz.yahoo.com logoQ2 2016 Raptor Pharmaceutical Corp Earnings Release - After Market Close (NASDAQ:RPTP)
biz.yahoo.com - August 4 at 10:22 AM
finance.yahoo.com logoACADIA (ACAD) Q2 Earnings: What's in Store for the Stock? (NASDAQ:RPTP)
finance.yahoo.com - August 2 at 12:09 PM
News IconTop Earnings to Watch for: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) - The Voice Registrar (NASDAQ:RPTP)
voiceregistrar.com - August 1 at 6:57 PM
investornewswire.com logoCan Shares Of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Hit $11? - Investor Newswire (NASDAQ:RPTP)
www.investornewswire.com - July 29 at 7:22 PM
publicnow.com logoRaptor Pharmaceutical to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4, 2016, at 4:30 p.m. EDT (NASDAQ:RPTP)
www.publicnow.com - July 28 at 7:58 AM
investornewswire.com logoIs $11 Price Target Attainable For Raptor Pharmaceutical Corp. (NASDAQ:RPTP)? - Investor Newswire (NASDAQ:RPTP)
www.investornewswire.com - July 23 at 6:40 PM
News IconRaptor Pharmaceutical Corp. on Focus After Raising In Today's Session - Consumer Eagle (NASDAQ:RPTP)
www.consumereagle.com - July 22 at 10:07 AM
News IconRaptor Pharmaceutical Corporation (NASDAQ:RPTP) Shorted Shares Increased By 5.98% - Consumer Eagle (NASDAQ:RPTP)
www.consumereagle.com - July 22 at 10:07 AM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:RPTP)
www.engelwooddaily.com - July 21 at 10:02 AM
news.cmlviz.com logoRaptor Pharmaceuticals Corp. Price Volatility Hits An Elevated Level - CML News (NASDAQ:RPTP)
news.cmlviz.com - July 21 at 10:02 AM
fiscalstandard.com logoRaptor Pharmaceutical Corp. (RPTP) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:RPTP)
www.fiscalstandard.com - July 17 at 11:16 AM
News IconHow Analysts Feel About Raptor Pharmaceutical Corp. (NASDAQ:RPTP)? - Consumer Eagle (NASDAQ:RPTP)
www.consumereagle.com - July 16 at 10:26 AM
investornewswire.com logoStrong Sell Calls For Raptor Pharmaceutical Corp. (NASDAQ:RPTP) At 0 - Investor Newswire (NASDAQ:RPTP)
www.investornewswire.com - July 16 at 10:26 AM

Social

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff